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Discussion: Immunization with an avirulent live S choleraesuis vaccine has demonstrated consistent
clinical and bacteriologic control of S choleraesuis infections in swine. Clinical signs, including febrile
response, diarrhea and mortality, along with growth rate, are significantly improved (p<0.05). Pigs
from one day of age and older may be safety vaccinated intranasally, or orally, via drinking water,
against disease associated with S choleraesuis, and to reduce the culture prevalence and shedding
of other serovars of Salmonellae (Nolan et al., 2000). Additionally, levels of the organism are effectively
reduced in vaccinated, challenged pigs. Fecal shedding of S choleraesuis is significantly lower in
vaccinated challenged pigs as compared to challenged control pigs. Organ culture prevalence is
likewise dramatically lowered in vaccinated pigs. Vaccination at one day of age is at least as
efficacious, and may offer even greater advantage over non vaccinated controls. 
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Summary: Two field studies and one laboratory challenge were performed to evaluate of vaccination
with a live, avirulent Salmonella choleraesuis vaccine (Enterisol® SC-54) to provide cross protection,
reduce the level of internal culture and fecal shedding of multiple serovars of Salmonella. Barns of
grow-finish pigs were vaccinated orally, via drinking water, or left as matched controls in the field studies.
Ileocecal lymph nodes and spiral colon fecal material were collected at the abattoir from field
studies. Three week old pigs were vaccinated intranasally and challenged at five weeks of age in
the laboratory study. Internal organ culture and fecal shedding were measured two weeks following
challenge with S typhimurium. In all three studies, vaccinated pigs had significantly lower culture
prevalence of non S choleraesuis serovars (p<0.05), and reduced fecal shedding in following laboratory
challenge (p<0.05). A nominal (p=0.07) trend to improved growth rate following laboratory challenge
with S typhimurium challenge was also detected.
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Introduction: Salmonella infections in pork have been linked to outbreaks of food born disease in
humans, attracting attention to those strategies that may help reduce Salmonella in pork (Letellier
et al., 2001). Those practices that reduce the level of contamination or carriage of Salmonella in
carcasses that arrive at abattoirs should assist in reducing Salmonella contamination of post-harvest
pork products. Enterisol® SC-54 (Boehringer Ingelheim Animal Health GmbH), an avirulent live Salmonella
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choleraesuis vaccine, has been utilized successfully to control clinical disease associated with
Salmonella choleraesuis in pigs (Roof et al., 1992). The purpose of these studies was to demonstrate
reduction of Salmonella shedding and culture prevalence in carcasses (Baum, 1997) and reduction
of sero-prevalence at slaughter (Nolan et al., 2000) in commercial production systems, and following
a laboratory challenge. These studies included reduction of Salmonella contamination of carcasses
at harvest in two conventional production systems, and a reduction in culture and shedding S
typhimurium in a laboratory challenge.
Materials and Methods: In two large field studies (>50,000 pigs), grow-finish pigs from two production
systems were randomly assigned at placement to finishing into either vaccinated or control groups
(barn = Exp. Unit). Control and vaccinated barns were matched by animal source, feed source, field
management, barn type and season. In most cases control barns were housed at the same location
as vaccinated pigs. Vaccine was administered orally, via drinking water, at placement to grow-finish.
Facilities were managed in an all in/all out fashion. Total slat, confined finishing barns were used for
all groups in study one. Study two utilized partially slatted finishing barns. Other variables that might
affect Salmonella contamination, e.g. feed type and source, pig source, pre-harvest handling, etc,
were consistent between each group (Dahl et al., 1996). Each treatment consisted of 12 or more
groups of animals in each study.
A random sample of 35 pigs from each group were selected from either the middle (study one) or
last marketing group (study two), and transported by clean, disinfected livestock trailers to the abattoir.
Pigs were held for a maximum of three hours prior to harvest. Power calculations for selecting sample
size were based on alpha <0.05 and beta >0.8 statistical criteria. 
Pig identity was established, and viscera sets (lung, liver, intestines) were individually bagged in clean
plastic bags. The viscera were removed to a separate clean room at the facility for collection of
ileocecal lymph nodes (study one and two) and spiral colon fecal content (study two only). Additionally,
blood and diaphragmatic samples were collected from a random subset of pigs. Culture processes
and organ selection followed previously described methods (Hurd et al., 2001). Field collection and
laboratory personnel were blinded to source (vaccinated or control) during culture, serotyping and
external identification of serovar. The Danish Mix ELISA test was utilized to determine the correlation
of group culture status vs. serologic status.
In the laboratory challenge, three week old pigs were obtained from a farm with no history of clinical
Salmonellosis in nursery age animals. Pigs were blocked by weight and sex, and randomly assigned
to vaccinated (n=20), strict control (10) or challenge control (10) groups. Vaccinated pigs received
one dose of Enterisol® SC-54 intranasally, while challenge controls received diluent placebo. Pigs
were maintained for two weeks in isolated rooms on wire flooring prior to oral challenge with virulent
S typhimurium to allow for development of immunity. Fecal culture was performed in all groups both
prior to and during the challenge study period. 
Vaccinated and challenge control pigs were challenged orally with >108 virulent S typhimurium. Pigs
were evaluated for clinical signs, weight gain and fecal shedding for a period of two weeks following
challenge. At the end of the two week period, animals were humanely euthanized and internal
organs (lung, liver, spleen, lymph node) and fecal samples collected for bacteriologic culture. Methods
utilized have been previously described (Hurd et al., 2001).
Results: Vaccinated pigs demonstrated a statistically significant reduction in the percent of carcasses
culture positive for Salmonella at slaughter in both field studies. In study one, vaccinated pigs had
12% of ileocecal lymph nodes culture positive for Salmonella species as compared to 24% of non
vaccinated pigs (p<0.05). On serologic examination, 14% of vaccinated pigs were seropositive on
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the Mix-ELISA, significantly less than the 26% of seropositive control pigs (p<0.05). Individual serum
samples were considered positive on Mix-ELISA at OD % 40 or above. 
In study two, vaccinated groups of pigs averaged 7.4% culture positive in ileocecal lymph nodes, as
compared to 26.8% in non vaccinated controls, again a significant reduction (p=0.03). Prevalence in
non-vaccinated control pigs was similar to other surveys in both studies (Hurd, 2002). Reduction was
significant for all Salmonella species, and non S choleraesuis species as a group. S typhimurium and
S derby were the most commonly isolated organisms from the ileocecal lymph nodes. Vaccinated
groups averaged 10.2% seropositive, while non vaccinated control groups had a mean of 24%
seropositive. Due to a wide range of seroprevalence in controls (sd=31%), the difference between groups
was not significant at the sample size utilized (p>0.1).
A trend toward reduction of Salmonella prevalence in spiral colon fecal samples was also noted in
study two (p=0.1). Thirty-two percent of non-vaccinated pigs had Salmonella detected in fecal samples,
as compared to 12.9% in vaccinated pigs. The relatively small number of study groups (only 10 groups
of each treatment were collected) compared to the high variability in control group fecal culture
prevalence (sd = 37.5%) suggests insufficient power in the fecal sample portion of the study. A sample
size of 43 groups would be required for alpha <0.05 with the same means, and the same standard
deviation in the control pigs. S typhimurium and S derby were the most commonly isolated organisms
from spiral colon fecal samples.
The correlation r2 of group culture status vs. serologic status was 0.67. Culture positive was defined
as one or more ileocecal lymph nodes culture positive. Seropositive groups were defined as one or
more serum samples positive on Mix-ELISA (OD % 40 or above). One group of pigs was 57% culture
positive (13 positive for S derby, 2 for S anatum and 1 S typhimurium) at slaughter but was seronegative.
Pen fecal samples collected prior to harvest of this group contained S derby and S typhimurium,
suggesting a late finishing exposure to S derby. This demonstrates the limits of categorization on the
basis serology using a point in time or intermittent basis, as compared to utilizing serology as part
of an ongoing sampling of a population of animals.
In the laboratory challenge study, at no point in time did strict (non challenged) controls have detectable
Salmonella in fecal or organ culture, indicating effect control of unintentional exposure. Only three of
twenty vaccinated pigs had detectable S typhimurium in organs or feces at post mortem 14 days
following challenge. In contract, all 10 control pigs were positive. Thirteen of 20 vaccinated pigs shed
S typhimurium for one or more days during the study period, while seven vaccinated pigs did not
have detectable shedding. All ten control pigs shed S typhimurium for at least one day during the study
period. Both measures showed significant (p<0.05) reduction in S typhimurium in organs or feces in pigs
receiving a live avirulent S choleraesuis vaccine. These findings are consistent with those of Baum
(1997) that demonstrated an association of Salmonella exposure with reduced performance. 
Vaccinated pigs did not seroconvert on the Danish Mix-ELISA. Subsequent examination of serum
samples using a commercial Salmonella LPS ELISA (Idexx Laboratories, Westbrook, Maine) has shown
similar lack of seroconversion in pigs vaccinated with Enterisol® SC-54. One possible explanation for
this phenomenon is the lack of the vpl virulence plasmid in the vaccine isolate (Kennedy et al., 1999).
Regardless the mechanism, the ability to utilize a commercial serologic kit to evaluate exposure to
field Salmonella in vaccinated animals would be a valuable epidemiologic tool.
Discussion: Several studies have suggested that vaccination with an avirulent live Salmonella vaccine
may allow for cross protection and reduction of Salmonella in several species (Fox et al., 1997; House
et al., 2001). The results of the three independent studies described further support the following
conclusions regarding vaccination of pigs with Enterisol® SC-54:
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a.) Vaccination reduces Salmonella prevalence in carcasses at harvest.
b.) Reduction occurs in all species of Salmonella, not just homologous/Group C1 Salmonellae.
c.) Vaccination can be a valuable tool in reducing risk of foodborne disease due to Salmonella in
pork. Vaccination will not interfere with serologic categorization of farms’ Salmonella status.
Vaccination may be considered as another potential tool for improving safety of pork by means of
reducing the level of salmonella contamination of pork carcasses, and potentially ground or other
fresh pork products. Commercial serologic tests may be utilized in conjunction with vaccination to
evaluate the success of Salmonella reduction programs in swine.
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Summary: This study’s goal was to evaluate the impact of sub-therapeutic feeding of chlortetracycline
(CTC) on the fecal concentration of tet(C), a gene that confers tetracycline resistance via an efflux
mechanism. We developed a real-time quantitative PCR assay to measure the quantity of tet(C) in
whole fecal DNA samples. The vast proportion of variability in tet(C) (91%) was associated with
differences in concentration between the individual pigs, and there was no significant difference in
the copy number of tet(C)/mg of feces between the treatment and control pigs (p>0.05, linear
regression, SPSS 11.0.5)
Keywords: real-time quantitative PCR, tet(C)
Introduction: Antimicrobial resistance (AR) research has been predominantly confined to the study
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